Cargando…
Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis
BACKGROUND: Metastasis is responsible for the majority of deaths in a variety of cancer types, including breast cancer. Although several factors or biomarkers have been identified to predict the outcome of patients with breast cancer, few studies have been conducted to identify metastasis-associated...
Autores principales: | Zeng, Liang, Deng, Xiyun, Zhong, Jingmin, Yuan, Li, Tao, Xiaojun, Zhang, Sai, Zeng, Yong, He, Guangchun, Tan, Pingping, Tao, Yongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708189/ https://www.ncbi.nlm.nih.gov/pubmed/31443698 http://dx.doi.org/10.1186/s12885-019-6016-3 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Identification of Nucleobindin-2 as a Potential Biomarker for Breast Cancer Metastasis Using iTRAQ-based Quantitative Proteomic Analysis
por: Zeng, Liang, et al.
Publicado: (2017) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)